🔴 Context Therapeutics Inc is trading 11.4% down today amid a broad biotech selloff and hawkish rate expectations

Context Therapeutics Inc is trading 11.4% down at $2.00 following a sharp session decline driven by a broad market selloff rather than company-specific news.

• The Nasdaq fell 3.47% as hotter-than-expected jobs data fueled hawkish interest rate expectations, weighing heavily on growth and biotech sectors.
• No company-specific catalysts, such as earnings, FDA updates, or merger news, were identified to account for the move.